Skip to main content

Table 2 Relationship between NEIL3 expression and clinicopathology in our LUAD cohort

From: NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma

Characteristics n NEIL3 χ2 P value
Low expression High expression
Total 406 228 178   
Age 1.082 0.298
 ≤ 60 146 77 (52.74) 69 (47.26)   
 > 60 260 151 (58.08) 109 (41.92)   
Gender 2.814 0.093
 Male 249 148 (59.44) 101 (40.56)   
 Female 157 80 (50.96) 77 (49.04)   
TNM stage 1.81 0.178
 I and II 312 169 (54.17) 143 (45.83)   
 III and IV 94 59 (62.77) 35 (37.23)   
Tumor stage 14.648 0.002*
 I 203 124 (61.08) 79 (38.92)   
 II 145 81 (55.86) 64 (44.14)   
 III 32 8 (25.00) 24 (75.00)   
 IV 26 15 (57.69) 11 (42.31)   
Metastasis stage 0.001 0.971
 Negative 397 223 (56.17) 174 (43.83)   
 Positive 9 5 (55.56) 4 (44.44)   
Node stage 0.88 0.348
 Negative 222 120 (54.05) 102 (45.94)   
 Positive 184 108 (58.70) 76 (41.30)   
  1. *Statistically significant